1. Home
  2. NAC vs ANIP Comparison

NAC vs ANIP Comparison

Compare NAC & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen California Quality Municipal Income Fund

NAC

Nuveen California Quality Municipal Income Fund

HOLD

Current Price

$11.78

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$85.87

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NAC
ANIP
Founded
1998
2001
Country
France
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NAC
ANIP
Price
$11.78
$85.87
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$107.33
AVG Volume (30 Days)
307.3K
525.1K
Earning Date
01-01-0001
02-27-2026
Dividend Yield
4.33%
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.67
Revenue
N/A
$826,880,000.00
Revenue This Year
N/A
$44.37
Revenue Next Year
N/A
$9.83
P/E Ratio
N/A
$51.06
Revenue Growth
N/A
48.87
52 Week Low
$9.32
$54.10
52 Week High
$11.21
$99.50

Technical Indicators

Market Signals
Indicator
NAC
ANIP
Relative Strength Index (RSI) 41.49 58.46
Support Level $11.75 $83.03
Resistance Level $11.87 $87.07
Average True Range (ATR) 0.08 3.49
MACD -0.02 0.80
Stochastic Oscillator 7.46 89.93

Price Performance

Historical Comparison
NAC
ANIP

About NAC Nuveen California Quality Municipal Income Fund

Nuveen California Quality Municipal Income Fund is a closed-end fixed income mutual fund that prominently invests in tax-exempt municipal bonds from California. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Arizona individual income taxes. Its portfolio mainly includes investment-grade municipal securities of California. The fund targets various sectors such as healthcare, utilities, transportation, and consumer staples.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: